Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment
ISRCTN ISRCTN21277091
ClinicalTrials.gov identifier
Public title Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis To determine the efficacy of teaching patients with bipolar disorder (manic-depressive psychosis) to identify early symptoms of relapse and seek prompt treatment from health services.
Lay summary
Ethics approval The study was approved by a medical ethics committee in each NHS trust. Each patient gave written informed consent to the trial.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Schizophrenia and other psychoses
Participants - inclusion criteria 1. A lifetime diagnosis of bipolar disorder elicited by a trained research assistant using a standardised psychiatric interview
2. Two or more relapses
3. One in the previous 12 months
4. Aged 18 to 75 years
Participants - exclusion criteria 1. An inability to read or write in English
2. Drug or alcohol misuse or dependence as a primary problem
3. An organic cerebral cause for bipolar disorder, e.g., multiple sclerosis or stroke
Anticipated start date 01/03/1994
Anticipated end date 01/04/1997
Status of trial Completed
Patient information material
Target number of participants 69
Interventions 7 - 12 intervention treatment sessions from a research psychologist plus routine care versus routine care only.
Primary outcome measure(s) 1. Time to first manic or depressive relapse
2. Number of manic or depressive relapses
3. Social functioning examined by standardised interviews every six months for 18 months
Secondary outcome measure(s) Not provided at time of registration
Sources of funding NHS Executive North West (UK)
Trial website
Publications 1999 results on http://www.ncbi.nlm.nih.gov/pubmed/9888904
Contact name Dr  Richard  Morriss
  Address Department of Community Psychiatry
University of Manchester
Withington Hospital
  City/town Manchester
  Zip/Postcode M20 8LR
  Country United Kingdom
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 23/01/2004
Last edited 01/06/2009
Date ISRCTN assigned 23/01/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central